Today, a Director at Healthequity, Evelyn Dilsaver, exercised options of Healthequity (NASDAQ: HQY) for $1.16M.
Following Evelyn Dilsaver’s last HQY Sell transaction on August 06, 2014, the stock climbed by 60.7%. This is Dilsaver’s first transaction since reporting a Sell transaction on AROPQ back in December 2016
See today’s analyst top recommended stocks >>
Based on Healthequity’s latest earnings report for the quarter ending April 30, the company posted quarterly revenue of $69.9 million and quarterly net profit of $22.58 million. In comparison, last year the company earned revenue of $55.42 million and had a net profit of $14.03 million. HQY’s market cap is $4.81B and the company has a P/E ratio of 88.26. Currently, Healthequity has an average volume of 353.7K.
Based on 7 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $78.71, reflecting a -0.2% downside.
The insider sentiment on Healthequity has been negative according to 91 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Evelyn Dilsaver’s trades have generated a 31.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HealthEquity, Inc. engages in the provision of healthcare saving solutions. Its products include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.
